Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · IEX Real-Time Price · USD
3.050
+0.180 (6.27%)
At close: May 10, 2024, 4:00 PM
3.120
+0.070 (2.30%)
After-hours: May 10, 2024, 7:47 PM EDT
Turnstone Biologics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Turnstone Biologics stock have an average target of 19, with a low estimate of 18 and a high estimate of 20. The average target predicts an increase of 522.95% from the current stock price of 3.05.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 15, 2023.
Analyst Ratings
The average analyst rating for TSBX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +490.16% | Aug 15, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $20 | Buy | Initiates | $20 | +555.74% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
from 19.31M
Revenue Next Year
n/a
EPS This Year
-2.82
from -4.78
EPS Next Year
-2.93
from -2.82
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.54 | -2.88 | -3.61 |
| Avg | -2.82 | -2.93 | -3.51 |
| Low | -3.04 | -2.94 | -3.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.